Roche's new immunotherapy tiragolumab fails main goal of phase 3 trial in lung cancer
March 30 2022 - 4:54AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024